Brief: Pmv Pharmaceuticals Reports First Quarter 2022 Financial Results And Corporate Highlights
10/05/2022 12:31
May 10 (Reuters) - PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND CORPORATE HIGHLIGHTS
* QTRLY LOSS PER SHARE $0.41
* AS OF MARCH 31, 2022, CO. HAD $294.8 MILLION IN CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES
* Q1 EARNINGS PER SHARE VIEW $-0.40 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX24MCrn
Further company coverage: PMVP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics